Compare FSI & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FSI | SERA |
|---|---|---|
| Founded | 1991 | 2008 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Precision Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.7M | 75.2M |
| IPO Year | 2000 | 2021 |
| Metric | FSI | SERA |
|---|---|---|
| Price | $6.03 | $1.84 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 12.2K | ★ 40.9K |
| Earning Date | 12-02-2026 | 11-04-2026 |
| Dividend Yield | ★ 1.69% | N/A |
| EPS Growth | N/A | ★ 32.32 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $15,494,325.00 | $81,000.00 |
| Revenue This Year | $24.09 | $146.91 |
| Revenue Next Year | $60.56 | $933.34 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 5.19 |
| 52 Week Low | $4.85 | $1.56 |
| 52 Week High | $7.52 | $3.85 |
| Indicator | FSI | SERA |
|---|---|---|
| Relative Strength Index (RSI) | 39.73 | 38.78 |
| Support Level | $5.82 | $1.65 |
| Resistance Level | $6.11 | $2.15 |
| Average True Range (ATR) | 0.21 | 0.14 |
| MACD | -0.07 | -0.02 |
| Stochastic Oscillator | 2.13 | 11.90 |
Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The company also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.
Sera Prognostics Inc is a health diagnostic company. It is a women's health company utilizing the proprietary proteomics and bioinformatics platform, and data resources to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.